Patent · US Active

Crystallized recombinant human growth factor formulations

US8071544B2 · kind B2 · utility

2Cited by
4References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 13, 2007
Grant dateDec 6, 2011
Priority date
Expiry dateDec 13, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Formulations containing complexed human growth hormone crystals are described. Also described are needleless injection systems for crystalline proteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.